T-cell depletion of an HLA-haploidentical graft is often used to prevent graft-vs.-host disease (GvHD), but the procedure may lead to increased graft failure, relapse, and infections due to delayed immune recovery. We hypothesized that selective depletion of the CD45RA+ subset can effectively reduce GvHD through removal of naïve T cells, while providing improved donor immune reconstitution through adoptive transfer of CD45RA – memory T cells. Herein, we present results from the first 17 patients with poor-prognosis hematologic malignancy who received haploidentical donor transplantation with CD45RA-depleted progenitor cell grafts following a novel reduced intensity conditioning regimen without total body irradiation or serotherapy. Extensiv...
An important barrier to the success of transplanting haploidentical hematopoietic stem cells is dela...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...
In haploidentical stem cell transplantation (SCT), achieving a balance between graft versus host dis...
In haploidentical stem cell transplantation (SCT), achieving a balance between graft versus host dis...
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment available f...
Allogeneic haematopoietic stem cell transplantation (HSCT) from an human leukocyte antigen (HLA)-ide...
Haploidentical stem cell transplantation (SCT) has been generally performed using a T cell depleted ...
HLA-haploidentical family donors represent a valuable option for children requiring allogeneic hemat...
Viral infections and reactivations remain a serious obstacle to successful hematopoietic stem cell t...
HLA-haploidentical family donors represent a valuable option for children requiring allogeneic hemat...
Hematopoietic stem cell transplantation from haploidentical donors is an attractive method of transp...
BACKGROUND: Immune reconstitution following transplantation in individuals who had received T-cell-d...
BACKGROUND: Immune reconstitution following transplantation in individuals who had received T-cell-d...
The CD45RA T cell depletion (TCD) method has been used to deplete naive T cells, preventing graft-ve...
An important barrier to the success of transplanting haploidentical hematopoietic stem cells is dela...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...
In haploidentical stem cell transplantation (SCT), achieving a balance between graft versus host dis...
In haploidentical stem cell transplantation (SCT), achieving a balance between graft versus host dis...
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment available f...
Allogeneic haematopoietic stem cell transplantation (HSCT) from an human leukocyte antigen (HLA)-ide...
Haploidentical stem cell transplantation (SCT) has been generally performed using a T cell depleted ...
HLA-haploidentical family donors represent a valuable option for children requiring allogeneic hemat...
Viral infections and reactivations remain a serious obstacle to successful hematopoietic stem cell t...
HLA-haploidentical family donors represent a valuable option for children requiring allogeneic hemat...
Hematopoietic stem cell transplantation from haploidentical donors is an attractive method of transp...
BACKGROUND: Immune reconstitution following transplantation in individuals who had received T-cell-d...
BACKGROUND: Immune reconstitution following transplantation in individuals who had received T-cell-d...
The CD45RA T cell depletion (TCD) method has been used to deplete naive T cells, preventing graft-ve...
An important barrier to the success of transplanting haploidentical hematopoietic stem cells is dela...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...